Structure-activity relationships for three macrolide antibiotics in Haemophilus influenzae

Current Microbiology

Volumn 49, Issue 4, 2004, Pages 248-254

  Mabe, Susan ^a   Eller, Jessica ^a   Champney, W Scott ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; FLURITHROMYCIN; MACROLIDE; ROXITHROMYCIN;

50S RIBOSOME SUBUNIT; ANTIMICROBIAL ACTIVITY; ARTICLE; BINDING KINETICS; CELL COUNT; CELL VIABILITY; CONCENTRATION RESPONSE; DRUG EFFICACY; GRAM NEGATIVE BACTERIUM; GROWTH RATE; HAEMOPHILUS INFLUENZAE; IC 50; INHIBITION KINETICS; LABELING INDEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; PULSE AND CHASE LABELING KINETICS; RIBOSOME SUBUNIT; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CLARITHROMYCIN; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE; MACROLIDES; RIBOSOMAL PROTEINS; ROXITHROMYCIN; STRUCTURE-ACTIVITY RELATIONSHIP;

BACTERIA (MICROORGANISMS); HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; NEGIBACTERIA;

EID: 4744355270     PISSN: 03438651     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00284-004-4312-9     Document Type: Article

References (35)

1. Alder JD, Ewing PJ, Nilus AM, Mitten M, Tovcimak A, Oleksijew A, et al. (1998) Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection. Antimicrob Agents Chemother 42:2385-2390
2. Aubery R, Tang C (2003) The pathogenesis of disease due to type b Haemophilus influenzae. In: Herbert MA, Hood DW, Moxon ER (eds) Haemophilus influenzae protocols. Humana Press, Totowa, NJ, pp. 29-50
3. Bergman KL, Olsen KM, Peddicord TE, Fey PD, Rupp ME (1999) Antimicrobial activities and postantibiotic effects of clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of Haemophilus influenzae and Streptococcus pneumoniae. Antimicrob Agents Chemother 43:1291-1293.
4. Berry V, Thorburn CE, Knott SJ, Woodnutt G (1998) Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. Antimicrob Agents Chemother 42:3193-3199
5. Blosser-Middleton R, Sahm DF, Thornsberry C, Jones ME, Hogan PA, Critchley IA, et al. (2003) Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001. Clin Microbiol Infect 9:431-436
6. Bryskier A (1998) Roxithromycin: Review of its antimicrobial activity. J Antimicrob Chemother 41:1-21
7. Campos J (2001) Haemophilus influenzae: From the post-vaccination era to antibiotic resistance. Clinical Microbiol Infect Dis 7:287-290
8. Champney WS (2001) Bacterial ribosomal subunit synthesis: A novel antibiotic target. Curr Drug Targets Infect Disord 1:19-36
9. Champney WS (2003) Bacterial ribosomal subunit assembly is an antibiotic target Curr Top Med Chem 3:929-947
10. Champney WS, Burdine R (1996) 50S Ribosomal subunit synthesis and translation are equivalent targets for erythromycin inhibition in Staphylococcus aureus. Antimicrob Agents Chemother 40:1301-1303
11. Champney WS, Burdine R (1998) Azithromycin and clarithromycin inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells. Curr Microbiol 36:119-123
12. Champney WS, Miller M (2002) Inhibition of 50S ribosomal subunit assembly in Haemophilus influenzae cells by azithromycin and erythromycin. Curr Microbiol 44:418-424
13. Champney WS, Pelt J (2002) The ketolide antibiotic ABT-773 is a specific inhibitor of translation and 50S ribosomal subunit formation in Streptococcus pneumoniae cells. Curr Microbiol 45:155-160
14. Champney WS, Pelt J (2002) Telithromycin inhibition of protein synthesis and 50S ribosomal subunit formation in Streptococcus pneumoniae cells. Curr Microbiol 45:328-333
15. Champney WS, Tober CL (2003) Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells. Curr Microbiol 46:103-108
16. Chittum HS, Champney WS (1995) Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells. Curr Microbiol 30:273-279
17. Facinelli B, Varaldo PE (1991) Activity of roxithromycin against respiratory pathogens. J Chemother 3 [Suppl 1]: 33-35
18. Fera MT, Giannone M, Pallio S, Tortora A, Blandino G, Carbone M (2001) Antimicrobial activity and postantibiotic effect of flurithromycin against Helicobacter pylori strains. Int J Antimicrob Agents 17:151-154
19. Furneri P, Nicoletti G, Russo G, Stefani S, Tempera G (1987) Further microbiological investigations of flurithromycin against gram-positive bacteria and mycoplasmas. Chemioterapia 6:161-163
20. Gialdroni Grassi G, Alesina R, Bersani C, Ferrara A, Fietta A, Peona V (1986) In vitro activity of flurithromycin, a novel macrolide antibiotic. Chemioterapia 5:177-184
21. Goldman RC, Fesik SW, Doran CC (1990) Role of protonated and neutral forms of macrolides in binding to ribosomes from Gram-positive and Gram-negative bacteria. Antimicrob Agents Chemother 34:426-431
22. Hansen JL, Ippolito JA, Ban N, Nissen P, Moore PB, Steitz TA (2002) The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol Cell 10:117-128
23. Hardy DJ, Hensey DM, Beyer JM, Vojtko C, McDonald E, Fernandes PB (1988) Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother 32: 1710-1719
24. Hogan PA, Sheehan DJ (1998) Macrolide susceptibility and β-lactamase production among Haemophilus influenzae isolates in the United States, 1996-1997. Antimicrob Agents Chemother 42: 3313-3314
25. Hopstaken RM, Nelemans P, Stobberingh EE, Muris JW, Rinkens PE, Dinant GJ (2002) Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial. J Fam Pract 51:329-336
26. Kirst HA (1993) Semi-synthetic derivatives of erythromycin. Prog Med Chem 30:57-88
27. Mazzei T, Mini E, Novelli A, Periti P (1993) Chemistry and mode of action of macrolides. J Antimicrob Chemother 31:1-9
28. Odenholt-Tornqvist I, Lowdin E, Cars O (1995) Postantibiotic efects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin and azithromycin on respiratory tract pathogens. Antimicrob Agents Chemother 39:221-226
29. Scaglione F, Rossoni G (1998) Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin. J Antimicrob Chemother 41:47-50
30. Schlünzen F, Harms JM, Franceschi F, Hansen HAS, Bartels H, Zarivach R, et al. (2003) Structural basis for the antibiotic activity of ketolides and azalides. Structure 11:329-338
31. Schlünzen F, Zarivach R, Harms J, Bashan A, Tocilj A, Albrecht R, et al. (2001) Structural basis for the interaction of antibiotics with the peptidyltransferase centre in eubacteria. Nature 413:814-821
32. Usary J, Champney WS (2001) Erythromycin inhibition of 50S ribosomal subunit formation in Escherichia coli cells. Mol Microbiol 40:951-962
33. Whitman MS, Tunkel AR (1992) Azithromycin and clarithromycin. Overview and comparison with erythromycin. Infect Control Hosp Epidemiol 13:357-368
34. Williams JD, Sefton AM (1993) Comparison of macrolide antibiotics. J Antimicrob Chemother 31 [Suppl C]:11-26
35. Zuckerman JM, Kaye KM (1995) The newer macrolides: Azithromycin and clarithromycin. Infect Dis Clin North Am 9:731-745